WVE
Wave Life Sciences Ltd.
$5.29
+0.76%
2026-08-21
About Wave Life Sciences Ltd.
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Key Fundamentals
Forward P/E
-4.54
EPS (TTM)
$-1.08
ROE
-67.4%
Revenue Growth (YoY)
-73.9%
Profit Margin
0.0%
Debt/Equity
9.61
Price/Book
1.96
Beta
-1.29
Market Cap
$1.07B
Avg Volume (10D)
3.7M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$6.65
60D Low
$5.01
Avg Volume
3.1M
Latest Close
$5.29
Get breakout alerts for WVE
Sign up for Breakout Scanner to receive daily notifications when WVE triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Wave Life Sciences Ltd. (WVE) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors WVE daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. WVE operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.